SO
Therapeutic Areas
Lucid Diagnostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EsoCheck® / EsoGuard® System | Detection of Barrett's Esophagus and associated dysplasia in at-risk patients (e.g., chronic GERD) | Commercial |
Leadership Team at Lucid Diagnostics
LA
Lishan Aklog, M.D.
Executive Chairman and Chief Executive Officer
DM
Dennis McGrath
Chief Financial Officer
MG
Marcy Graham
Chief Operating Officer
DF
David F. Hale
Director
AJ
Alfred J. Novak
Director
JL
James L. Cox, M.D.
Director
AC
Amitabh Chak, M.D.
Scientific Founder (University Hospitals Cleveland)
SM
Sanford Markowitz, M.D., Ph.D.
Scientific Founder (Case Western Reserve University)